MR diffusion weighted imaging for evaluation of radiotherapeutic effects on rabbit VX2 tumor model

Chinese Medical Sciences Journal

Volumn 23, Issue 3, 2008, Pages 172-177

  Li, Shuo ^a   Xue, Hua Dan ^a   Wang, Xin Hai ^a   Sun, Fei ^b   Jiang, Bo ^a   Liu, Dong ^a   Lei, Jing ^a   Jin, Zheng Yu ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b GE HEALTHCARE   (China)

Author keywords

Animal experiment; Diffusion magnetic resonance imaging; Radiotherapy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CANCER RADIOTHERAPY; CELL VIABILITY; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE DISPLAY; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT MONITORING; RADIATION INJURY; RADIATION NECROSIS; RADIATION RESPONSE; TUMOR CELL; TUMOR VOLUME;

EID: 55049117254     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(09)60034-1     Document Type: Article

References (15)

1. Deng J, Rhee TK, Sato KT, et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 2006; 41:410-4.
2. Moffat BA, Hall DE, Stojanovska J, et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 2004; 17:249-59.
3. Theilmann RJ, Borders R, Trouard TP, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004; 6:831-7
4. Mardor Y, Roth Y, Ochershvilli A, et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 2004; 6:136-42.
5. Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004; 232:685-92.
6. Smith WE, Kidd JG, Rous P, et al. Experiments of the cause of the rabbit carcinomas derived from virus-induced papilloma. Propagation of several of the cancers in sucklings with etiological tests. J Exp Med 1952; 95:299-317.
7. Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR 2003; 181: 708-10.
8. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999; 91:523-8.
9. Yang WT, Johnson PJ. Monitoring response to treatment in liver tumours. Baillieres Best Pract Res Clin Gastroenterol 1999; 13:637-54.
10. Low RN. Magnetic resonance imaging in the oncology patient: evaluation of the extrahepatic abdomen. Semin Ultrasound CT MR 2005; 26:224-36.
11. Chenevert TL, Stegman LD, Taylor JMG, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000; 92:2029-36.
12. Mardor Y, Roth Y, Ochershvilli A, et al. Pretreatment prediction of brain tumors response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 2004; 6:136-42.
13. Larson AC, Rhee TK, Deng J, et al. Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model. J Magn Reson Imaging 2006; 24:242-7.
14. Purdie TG, Lee TY. Carbon dioxide reactivity of computed tomography functional parameters in rabbit VX2 soft tissue tumour. Phys Med Biol 2003; 48:849-60.
15. Geschwind JFH, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000; 11:1245-55.